Detalles de la búsqueda
1.
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
Diabetes Obes Metab
; 2024 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38680053
2.
Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.
Cardiovasc Diabetol
; 22(1): 126, 2023 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244998
3.
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia.
Cardiovasc Diabetol
; 22(1): 233, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653496
4.
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
JAMA
; 330(13): 1266-1277, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37787795
5.
Obesity in late adolescence and incident type 1 diabetes in young adulthood.
Diabetologia
; 65(9): 1473-1482, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665825
6.
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
Cardiovasc Diabetol
; 21(1): 104, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35689214
7.
Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence.
Cardiovasc Diabetol
; 20(1): 169, 2021 08 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407822
8.
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.
Diabetes Obes Metab
; 23(6): 1431-1435, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606906
9.
Very Low Birth Weight Preterm Infants have Decreased Celiac Disease Autoimmunity During Childhood and Adolescence.
J Pediatr Gastroenterol Nutr
; 70(4): 478-481, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31961341
10.
Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: Real-world data analysis.
Diabetes Obes Metab
; 21(2): 340-348, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30207040
11.
Risk of hospitalization with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes lacking evidence of chronic kidney disease: Real-world data.
Diabetes Obes Metab
; 25(10): 3054-3058, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385956
12.
Real-World Use of Alirocumab: Experience from a Large Healthcare Provider.
J Clin Med
; 12(3)2023 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769732
13.
Long-Term, Real-World Kidney Outcomes with SGLT2i versus DPP4i in Type 2 Diabetes without Cardiovascular or Kidney Disease.
Clin J Am Soc Nephrol
; 18(9): 1153-1162, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37382938
14.
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study.
JMIR Public Health Surveill
; 9: e50110, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37933755
15.
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Diabetes Metab
; 49(2): 101418, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36608816
16.
Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes.
J Diabetes Complications
; 36(1): 108086, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799250
17.
Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort Study.
Pharmacoecon Open
; 5(3): 533-544, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905114
18.
The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in Israel.
Endocrinol Diabetes Metab
; 3(3): e00124, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32704550
19.
Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel.
Value Health Reg Issues
; 22: 83-92, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32798839
20.
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting.
Diabetes Ther
; 11(1): 185-196, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31808132